# Ukraine Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Ukraine HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Ukraine (UKR)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $138.3M
- Products: 41
- Buyer markets: 26
- Average CAGR: +106.4%
- Global sector size: $641.4B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $306.5B | $10.3M | $115.5B | +19.6% | 21 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $83.0B | $35.0M | $32.0B | +836.7% | 12 | +0.1% |
| HS 293359 - Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $19.4B | $1.4M | $23.0B | +20.7% | 3 | +0.0% |
| HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $16.3B | $2.3K | $16.8B | -11.3% | 3 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $21.8B | $378.8K | $16.2B | -4.0% | 7 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $25.3B | $416.7K | $13.6B | -2.1% | 4 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $19.3B | $77.3K | $11.0B | -12.4% | 5 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $10.1B | $1.9K | $10.4B | -12.9% | 2 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $6.8B | $60.0K | $9.6B | +14.8% | 2 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $13.4B | $4.4M | $8.5B | -3.3% | 3 | +0.0% |
| HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $13.5B | $19.8K | $8.5B | +51.7% | 3 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $15.1B | $16.8M | $6.3B | +31.3% | 3 | +0.1% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $14.9B | $267.4K | $5.9B | +44.1% | 2 | +0.0% |
| HS 290110 - Acyclic hydrocarbons: saturated | $2.9B | $3.8K | $5.1B | -21.1% | 2 | +0.0% |
| HS 293379 - Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) | $4.2B | $5.3K | $4.8B | -10.0% | 1 | +0.0% |
| HS 310420 - Fertilizers, mineral or chemical: potassic, potassium chloride | $6.4B | $3.0M | $4.5B | +184.3% | 2 | +0.2% |
| HS 290919 - Ethers: acyclic, and their halogenated, sulphonated, nitrated or nitrosated derivatives, other than diethyl ether | $3.0B | $15.8K | $4.4B | -2.3% | 2 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $6.6B | $936.2K | $4.1B | +6.2% | 2 | +0.0% |
| HS 381512 - Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with precious metal or precious metal compounds as the active substance, n.e.c. or included | $4.5B | $267.7K | $3.8B | +5.0% | 2 | +0.0% |
| HS 290220 - Cyclic hydrocarbons: benzene | $4.1B | $106.2K | $3.5B | -18.8% | 1 | +0.0% |
| HS 381800 - Chemical elements: doped for use in electronics, in the form of discs, wafers or similar forms: chemical compounds doped for use in electronics | $5.7B | $40.0K | $3.3B | -5.3% | 2 | +0.0% |
| HS 293590 - Sulphonamides: n.e.c. in heading no. 2935 | $3.1B | $497.9K | $2.9B | +29.0% | 2 | +0.0% |
| HS 284410 - Uranium: natural uranium and its compounds, alloys, dispersions (including cermets), ceramic products and mixtures containing natural uranium or natural uranium compounds | $1.9B | $13.9M | $2.6B | +3.7% | 1 | +3.7% |
| HS 282590 - Inorganic bases, metal oxides, hydroxides and peroxides: n.e.s. in heading no. 2825 | $1.5B | $91.1 | $2.4B | -12.3% | 1 | +0.0% |
| HS 285390 - Phosphides, chemically defined or not, not ferrophosphorus: other inorganic compounds n.e.c. (including distilled, conductivity water and water of like purity): liquid air, rare gases removed or not: compressed air: amalgams, not precious metal amalgams | $1.3B | $11.8 | $2.4B | -49.0% | 1 | +0.0% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $8.6K | $2.0B | +9.2% | 1 | +0.0% |
| HS 293299 - Heterocyclic compounds: with oxygen hetero-atom(s) only, no lactones or unfused furan rings (hydrogenated or not) in the structure, other than isosafrole, 1-(1,3-benzodiaxol-5-yl) propan-2-one, piperonal, safrole, tetrahydrocannabinols (all isomers) | $2.4B | $1.9M | $2.0B | +35.4% | 1 | +0.1% |
| HS 284590 - Isotopes (excluding those of heading no. 2844): compounds, inorganic or organic, of such isotopes, whether or not chemically defined | $1.1B | $255.3 | $1.9B | +18.9% | 1 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $338.9K | $1.9B | +60.1% | 1 | +0.0% |
| HS 281820 - Aluminium oxide: other than artificial corundum | $2.2B | $78.5K | $1.8B | -9.7% | 1 | +0.0% |
| HS 284420 - Uranium: enriched in U235, plutonium, their compounds, alloys dispersions (including cermets), ceramic products and mixtures containing uranium enriched in U235, plutonium or compounds of these products | $4.9B | $101.1 | $1.7B | -34.0% | 1 | +0.0% |
| HS 284390 - Inorganic or organic compounds: of precious metals (excluding gold and silver), whether or not chemically defined, amalgams of precious metals | $892.9M | $1.3K | $1.7B | +14.6% | 1 | +0.0% |
| HS 310540 - Fertilizers, mineral or chemical: ammonium dihydrogenorthophosphate (monoammonium phosphate) and mixtures thereof with diammonium hydrogenorthophosphate (diammonium phosphate) | $2.7B | $35.4M | $1.7B | +2.0% | 1 | +3.3% |
| HS 284690 - Compounds, inorganic or organic (excluding cerium), of rare-earth metals, of yttrium, scandium or of mixtures of these metals | $1.4B | $45.3 | $1.5B | -7.6% | 1 | +0.0% |
| HS 300670 - Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | $1.2B | $8.9 | $1.4B | -25.4% | 1 | +0.0% |
| HS 291736 - Acids: aromatic polycarboxylic acids: terephthalic acid and its salts | $1.6B | $1.6K | $1.4B | +32.7% | 1 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $1.3K | $1.4B | +10.7% | 1 | +0.0% |
| HS 310530 - Fertilizers, mineral or chemical: diammonium hydrogenorthophosphate (diammonium phosphate) | $2.7B | $11.0M | $1.3B | +13.1% | 1 | +0.3% |
| HS 293719 - Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts | $651.9M | $8.1K | $1.3B | +18.1% | 1 | +0.0% |
| HS 310221 - Fertilizers, mineral or chemical: nitrogenous, ammonium sulphate | $965.4M | $1.6M | $1.3B | +16.0% | 1 | +0.4% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $1.8B | $6.8K | $1.2B | +4.7% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $67.7B calculated opportunity across 17 products.
- Switzerland, Liechtenstein (CHE): $37.8B calculated opportunity across 5 products.
- Germany (DEU): $36.4B calculated opportunity across 11 products.
- Slovenia (SVN): $31.5B calculated opportunity across 3 products.
- China (CHN): $31.5B calculated opportunity across 11 products.
- Netherlands (NLD): $16.8B calculated opportunity across 4 products.
- Belgium (BEL): $16.1B calculated opportunity across 3 products.
- Mexico (MEX): $11.9B calculated opportunity across 6 products.
- Canada (CAN): $11.7B calculated opportunity across 6 products.
- Italy (ITA): $9.8B calculated opportunity across 2 products.
- United Kingdom (GBR): $9.6B calculated opportunity across 4 products.
- Japan (JPN): $9.6B calculated opportunity across 3 products.

## Growth stars

- HS 300215: +836.7% average CAGR, $32.0B calculated opportunity.
- HS 310420: +184.3% average CAGR, $4.5B calculated opportunity.
- HS 382319: +60.1% average CAGR, $1.9B calculated opportunity.
- HS 300214: +51.7% average CAGR, $8.5B calculated opportunity.
- HS 330499: +44.1% average CAGR, $5.9B calculated opportunity.
- HS 293299: +35.4% average CAGR, $2.0B calculated opportunity.
- HS 291736: +32.7% average CAGR, $1.4B calculated opportunity.
- HS 382200: +31.3% average CAGR, $6.3B calculated opportunity.
- HS 293590: +29.0% average CAGR, $2.9B calculated opportunity.
- HS 293359: +20.7% average CAGR, $23.0B calculated opportunity.

## Diversification opportunities

- HS 300490: 21 buyer markets, $115.5B calculated opportunity.
- HS 300215: 12 buyer markets, $32.0B calculated opportunity.
- HS 382499: 7 buyer markets, $16.2B calculated opportunity.
- HS 300439: 5 buyer markets, $11.0B calculated opportunity.
- HS 300212: 4 buyer markets, $13.6B calculated opportunity.
- HS 293359: 3 buyer markets, $23.0B calculated opportunity.
- HS 293399: 3 buyer markets, $16.8B calculated opportunity.
- HS 293499: 3 buyer markets, $8.5B calculated opportunity.
- HS 300214: 3 buyer markets, $8.5B calculated opportunity.
- HS 382200: 3 buyer markets, $6.3B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.